報道指陽光城(000671.SZ)中票疑遭外資做空
據《第一財經》報道,社交媒體上流日前流出一份債券發行人陽光城(000671.SZ)給中國銀行間市場交易商協會的投訴材料。文件中表示,陽光城的一期中票交易價格大幅偏離估值,交易方或涉嫌操縱市場和利益輸送。
報道稱,所謂「異常交易」的持有人是「HONG KONG MONETARY AUTHORITY CMU」,即香港金管局的賬戶,代表着交易方是離岸機構通過債券通進行的交易。
報道從多位知情人士確認,舉報方確實爲陽光城。陽光城方面則對此事暫不予置評。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.